ArticleOncotarget2016

PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.

Kenney R Roodakker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.